Copyright Reports & Markets. All rights reserved.

Global Newborn Disease Screening Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Newborn Disease Screening by Type
    • 1.3.1 Overview: Global Newborn Disease Screening Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Newborn Disease Screening Consumption Value Market Share by Type in 2024
    • 1.3.3 Hypothyroidism
    • 1.3.4 Phenylketonuria
    • 1.3.5 Galactosemia
    • 1.3.6 Sickle Cell Disease
    • 1.3.7 Others
  • 1.4 Global Newborn Disease Screening Market by Application
    • 1.4.1 Overview: Global Newborn Disease Screening Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 General Hospitals
    • 1.4.3 Specialty Clinics
  • 1.5 Global Newborn Disease Screening Market Size & Forecast
  • 1.6 Global Newborn Disease Screening Market Size and Forecast by Region
    • 1.6.1 Global Newborn Disease Screening Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Newborn Disease Screening Market Size by Region, (2020-2031)
    • 1.6.3 North America Newborn Disease Screening Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Newborn Disease Screening Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Newborn Disease Screening Market Size and Prospect (2020-2031)
    • 1.6.6 South America Newborn Disease Screening Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Newborn Disease Screening Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 AB Sciex
    • 2.1.1 AB Sciex Details
    • 2.1.2 AB Sciex Major Business
    • 2.1.3 AB Sciex Newborn Disease Screening Product and Solutions
    • 2.1.4 AB Sciex Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 AB Sciex Recent Developments and Future Plans
  • 2.2 Agilent Technologies
    • 2.2.1 Agilent Technologies Details
    • 2.2.2 Agilent Technologies Major Business
    • 2.2.3 Agilent Technologies Newborn Disease Screening Product and Solutions
    • 2.2.4 Agilent Technologies Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Agilent Technologies Recent Developments and Future Plans
  • 2.3 Bio-Rad Laboratories
    • 2.3.1 Bio-Rad Laboratories Details
    • 2.3.2 Bio-Rad Laboratories Major Business
    • 2.3.3 Bio-Rad Laboratories Newborn Disease Screening Product and Solutions
    • 2.3.4 Bio-Rad Laboratories Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.4 Cytiva
    • 2.4.1 Cytiva Details
    • 2.4.2 Cytiva Major Business
    • 2.4.3 Cytiva Newborn Disease Screening Product and Solutions
    • 2.4.4 Cytiva Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Cytiva Recent Developments and Future Plans
  • 2.5 Masimo
    • 2.5.1 Masimo Details
    • 2.5.2 Masimo Major Business
    • 2.5.3 Masimo Newborn Disease Screening Product and Solutions
    • 2.5.4 Masimo Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Masimo Recent Developments and Future Plans
  • 2.6 Medtronic
    • 2.6.1 Medtronic Details
    • 2.6.2 Medtronic Major Business
    • 2.6.3 Medtronic Newborn Disease Screening Product and Solutions
    • 2.6.4 Medtronic Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Medtronic Recent Developments and Future Plans
  • 2.7 Natus Medical
    • 2.7.1 Natus Medical Details
    • 2.7.2 Natus Medical Major Business
    • 2.7.3 Natus Medical Newborn Disease Screening Product and Solutions
    • 2.7.4 Natus Medical Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Natus Medical Recent Developments and Future Plans
  • 2.8 PerkinElmer
    • 2.8.1 PerkinElmer Details
    • 2.8.2 PerkinElmer Major Business
    • 2.8.3 PerkinElmer Newborn Disease Screening Product and Solutions
    • 2.8.4 PerkinElmer Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 PerkinElmer Recent Developments and Future Plans
  • 2.9 Zentech Manufacturing
    • 2.9.1 Zentech Manufacturing Details
    • 2.9.2 Zentech Manufacturing Major Business
    • 2.9.3 Zentech Manufacturing Newborn Disease Screening Product and Solutions
    • 2.9.4 Zentech Manufacturing Newborn Disease Screening Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Zentech Manufacturing Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Newborn Disease Screening Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Newborn Disease Screening by Company Revenue
    • 3.2.2 Top 3 Newborn Disease Screening Players Market Share in 2024
    • 3.2.3 Top 6 Newborn Disease Screening Players Market Share in 2024
  • 3.3 Newborn Disease Screening Market: Overall Company Footprint Analysis
    • 3.3.1 Newborn Disease Screening Market: Region Footprint
    • 3.3.2 Newborn Disease Screening Market: Company Product Type Footprint
    • 3.3.3 Newborn Disease Screening Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Newborn Disease Screening Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Newborn Disease Screening Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Newborn Disease Screening Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Newborn Disease Screening Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Newborn Disease Screening Consumption Value by Type (2020-2031)
  • 6.2 North America Newborn Disease Screening Market Size by Application (2020-2031)
  • 6.3 North America Newborn Disease Screening Market Size by Country
    • 6.3.1 North America Newborn Disease Screening Consumption Value by Country (2020-2031)
    • 6.3.2 United States Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Newborn Disease Screening Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Newborn Disease Screening Consumption Value by Type (2020-2031)
  • 7.2 Europe Newborn Disease Screening Consumption Value by Application (2020-2031)
  • 7.3 Europe Newborn Disease Screening Market Size by Country
    • 7.3.1 Europe Newborn Disease Screening Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 7.3.3 France Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Newborn Disease Screening Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Newborn Disease Screening Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Newborn Disease Screening Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Newborn Disease Screening Market Size by Region
    • 8.3.1 Asia-Pacific Newborn Disease Screening Consumption Value by Region (2020-2031)
    • 8.3.2 China Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 8.3.5 India Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Newborn Disease Screening Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Newborn Disease Screening Consumption Value by Type (2020-2031)
  • 9.2 South America Newborn Disease Screening Consumption Value by Application (2020-2031)
  • 9.3 South America Newborn Disease Screening Market Size by Country
    • 9.3.1 South America Newborn Disease Screening Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Newborn Disease Screening Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Newborn Disease Screening Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Newborn Disease Screening Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Newborn Disease Screening Market Size by Country
    • 10.3.1 Middle East & Africa Newborn Disease Screening Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Newborn Disease Screening Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Newborn Disease Screening Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Newborn Disease Screening Market Drivers
  • 11.2 Newborn Disease Screening Market Restraints
  • 11.3 Newborn Disease Screening Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Newborn Disease Screening Industry Chain
  • 12.2 Newborn Disease Screening Upstream Analysis
  • 12.3 Newborn Disease Screening Midstream Analysis
  • 12.4 Newborn Disease Screening Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Newborn Disease Screening market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

    This report is a detailed and comprehensive analysis for global Newborn Disease Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Newborn Disease Screening market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Newborn Disease Screening market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Newborn Disease Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Newborn Disease Screening market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Newborn Disease Screening
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Newborn Disease Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AB Sciex, Agilent Technologies, Bio-Rad Laboratories, Cytiva, Masimo, Medtronic, Natus Medical, PerkinElmer, Zentech Manufacturing, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Newborn Disease Screening market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hypothyroidism
    Phenylketonuria
    Galactosemia
    Sickle Cell Disease
    Others
    Market segment by Application
    General Hospitals
    Specialty Clinics
    Market segment by players, this report covers
    AB Sciex
    Agilent Technologies
    Bio-Rad Laboratories
    Cytiva
    Masimo
    Medtronic
    Natus Medical
    PerkinElmer
    Zentech Manufacturing
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Newborn Disease Screening product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Newborn Disease Screening, with revenue, gross margin, and global market share of Newborn Disease Screening from 2020 to 2025.
    Chapter 3, the Newborn Disease Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Newborn Disease Screening market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Disease Screening.
    Chapter 13, to describe Newborn Disease Screening research findings and conclusion.

    Buy now